BRAEDEN TURNER: Open Payments
NPI 1881368173 · CHATOM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 35 payments from 9 companies in 2025. Trend: 2023 $1,017 · 2024 $661 · 2025 $810
Food & beverage: $810
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $286 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $163 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Lilly USA, LLC | 3 | $52 |
| Corium, LLC | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $30 |
| Averitas Pharma Inc. | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $19 |
Products named: Ozempic, Kerendia, BREZTRI, Wegovy, MOUNJARO, Azstarys, Rybelsus, FARXIGA.
Industry payments across AL — which companies pay providers there.
